Blood biomarker changes and relationships after low dose oral ketamine treatment for post-traumatic stress disorder (PTSD)
medRxiv Preprint Server March 2, 2025 Bonnie L. Quigley, Emerald Orr, Sophie Kafka et al. preprint
Ketamine has been investigated as a treatment alternative for PTSD for the last 20 years, yet there have been virtually no reports of biological changes or biomarker characterisation related to treatment. To address this significant gap, this study analysed blood samples from 25 participants with PTSD who took part in an open-label 6-week trial of low dose oral ketamine treatment. Serum and...